296 related articles for article (PubMed ID: 30579875)
1. Uterine pathology in transmasculine persons on testosterone: a retrospective multicenter case series.
Grimstad FW; Fowler KG; New EP; Ferrando CA; Pollard RR; Chapman G; Gomez-Lobo V; Gray M
Am J Obstet Gynecol; 2019 Mar; 220(3):257.e1-257.e7. PubMed ID: 30579875
[TBL] [Abstract][Full Text] [Related]
2. Endometrial findings among transgender and gender nonbinary people using testosterone at the time of gender-affirming hysterectomy.
Hawkins M; Deutsch MB; Obedin-Maliver J; Stark B; Grubman J; Jacoby A; Jacoby VL
Fertil Steril; 2021 May; 115(5):1312-1317. PubMed ID: 33583596
[TBL] [Abstract][Full Text] [Related]
3. Ovarian Histopathology in Transmasculine Persons on Testosterone: A Multicenter Case Series.
Grimstad FW; Fowler KG; New EP; Ferrando CA; Pollard RR; Chapman G; Gray M; Gomez Lobo V
J Sex Med; 2020 Sep; 17(9):1807-1818. PubMed ID: 32703706
[TBL] [Abstract][Full Text] [Related]
4. The effect of testosterone on ovulatory function in transmasculine individuals.
Taub RL; Ellis SA; Neal-Perry G; Magaret AS; Prager SW; Micks EA
Am J Obstet Gynecol; 2020 Aug; 223(2):229.e1-229.e8. PubMed ID: 32044312
[TBL] [Abstract][Full Text] [Related]
5. Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals.
Loverro G; Resta L; Dellino M; Edoardo DN; Cascarano MA; Loverro M; Mastrolia SA
Taiwan J Obstet Gynecol; 2016 Oct; 55(5):686-691. PubMed ID: 27751416
[TBL] [Abstract][Full Text] [Related]
6. Endometrial thickness assessed by transvaginal ultrasound in transmasculine people taking testosterone compared with cisgender women.
Asseler JD; Caanen MR; Verhoeven MO; Huirne JAF; Goddijn M; van Dulmen-den Broeder E; Overbeek A; Lambalk CB; van Mello NM
Reprod Biomed Online; 2022 Nov; 45(5):1033-1038. PubMed ID: 35918245
[TBL] [Abstract][Full Text] [Related]
7. Contraception across the transmasculine spectrum.
Krempasky C; Harris M; Abern L; Grimstad F
Am J Obstet Gynecol; 2020 Feb; 222(2):134-143. PubMed ID: 31394072
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics and Histologic Features of Hysterectomy Specimens From Transmasculine Individuals.
Cao CD; Amero MA; Marcinkowski KA; Rosenblum NG; Chan JSY; Richard SD
Obstet Gynecol; 2021 Jul; 138(1):51-57. PubMed ID: 34259463
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcomes following resectoscopic endometrial ablation of non-atypical endometrial hyperplasia in women with abnormal uterine bleeding.
Vilos GA; Oraif A; Vilos AG; Ettler H; Edris F; Abu-Rafea B
J Minim Invasive Gynecol; 2015 Jan; 22(1):66-77. PubMed ID: 25048567
[TBL] [Abstract][Full Text] [Related]
10. Implications for management of ovarian cancer in a transgender man: Impact of androgens and androgen receptor status.
Aubrey C; Saad N; Köbel M; Mattatall F; Nelson G; Glaze S
Gynecol Oncol; 2021 May; 161(2):342-346. PubMed ID: 33663874
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Exogenous Testosterone on Breast Cancer Risk in Transmasculine Individuals.
Gurrala RR; Kumar T; Yoo A; Mundinger GS; Womac DJ; Lau FH
Ann Plast Surg; 2023 Jan; 90(1):96-105. PubMed ID: 36534108
[TBL] [Abstract][Full Text] [Related]
12. Postoperative Vaginal Bleeding Concerns after Gender-Affirming Hysterectomy in Transgender Adolescents and Young Adults on Testosterone.
Cipres DT; Shim JY; Grimstad FW
J Pediatr Adolesc Gynecol; 2023 Feb; 36(1):33-38. PubMed ID: 36089115
[TBL] [Abstract][Full Text] [Related]
13. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
[TBL] [Abstract][Full Text] [Related]
14. Transgender men: clinical care and implications in reproductive medicine: introduction.
de Ziegler D; de Sutter P
Fertil Steril; 2021 Oct; 116(4):919-921. PubMed ID: 34399947
[TBL] [Abstract][Full Text] [Related]
15. Resectoscopic surgery in 10 women with abnormal uterine bleeding and atypical endometrial hyperplasia.
Vilos GA; Harding PG; Ettler HC
J Am Assoc Gynecol Laparosc; 2002 May; 9(2):138-44. PubMed ID: 11960037
[TBL] [Abstract][Full Text] [Related]
16. Morphological study of Pipelle biopsy specimens in cases of abnormal uterine bleeding.
Khadim MT; Zehra T; Ashraf HM
J Pak Med Assoc; 2015 Jul; 65(7):705-9. PubMed ID: 26160077
[TBL] [Abstract][Full Text] [Related]
17. [Total hysteroscopic endometrium resection: a critical analysis of indications, technique and results].
Burmucic R; Hofmann P; Schenk M; Pickel H
Gynakol Geburtshilfliche Rundsch; 1998; 38(3):119-30. PubMed ID: 9885352
[TBL] [Abstract][Full Text] [Related]
18. Endometrial Cancer in a Transgender Man with Prolonged Exogenous Testosterone Use.
Gill S; Anderson M; Neveu J
Obstet Gynecol; 2024 Apr; 143(4):e125-e128. PubMed ID: 38330401
[TBL] [Abstract][Full Text] [Related]
19. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
[TBL] [Abstract][Full Text] [Related]
20. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women.
Wise MR; Gill P; Lensen S; Thompson JM; Farquhar CM
Am J Obstet Gynecol; 2016 Nov; 215(5):598.e1-598.e8. PubMed ID: 27287687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]